Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
19 This discrepancy highlights the gap between efficacy observed in controlled trial settings and effectiveness in routine clinical practice
Lixisenatide in patients with type 2 diabetes and acute coronary syndrome
The increase of ROS in chondrocytes caused by aging may be the cause of oxidative damage of genomic and mitochondrial DNA (McCulloch et al., 2017)
Gut-related benefits generally show up in two to four weeks instead of days
EMBO J 25: 5083-93
Impact of Circulating Tumor DNA-Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors
US$ 20.33
US$ 27.28
US$ 27.19
US$ 25.15
US$ 28.06
